Announcements
Radiopharm Theranostics
ASX Announcements
Stay fully informed with all investment-related announcements from Radiopharm Theranostics lodged with the ASX, including financial results, clinical trial updates, and corporate governance.
Recent News
Categories
Tags
Archives
Archives
RSS
- Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
- RAD Presentation December 2025
- Zacks Small-Cap Research
- Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs
- CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025
- Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
Analyst Reports
Analyst Coverage
| Analyst | Firm |
|---|---|
| John Hester | Bell Porter (Australia) |
| Yuan Zhi, PhD | B. Riley Securities |
| Kemp Dolliver, CFA | Brookline Capital Markets |
| Justin Walsh, PhD | Jones Trading |
| Jason McCarthy, PhD | Maxim Group |
| Ashok Kumar, PhD, CFA | Think Equity |
| John D. Vandemosten | Zacks Small Cap Research |
